Jun 7, 2021 08:30AM RenovaCare Clinical Trial to Start at U.S. Burn Centers

Jun 1, 2021 08:30AM RenovaCare Responds to SEC Complaint

May 6, 2021 08:30AM FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial

Mar 30, 2021 08:30AM RenovaCare Announces Organizational Changes and Appointment of New Officers

Feb 25, 2021 08:30AM RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021

Jan 19, 2021 08:30AM RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021

Jan 8, 2021 08:30AM RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference

Dec 22, 2020 08:00AM RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook

Nov 19, 2020 08:15AM RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones

Oct 22, 2020 04:35PM RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020

Oct 5, 2020 04:28PM RenovaCare Elects Alan L. Rubino to Chairman of the Board of Directors

Sep 15, 2020 08:30AM RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference

Aug 11, 2020 08:30AM RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility

Aug 4, 2020 08:30AM RenovaCare Appoints Dr. Lydia M. Evans to Its Board of Directors and Increases Board Membership

Jul 1, 2020 08:30AM RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration

Jun 16, 2020 08:30AM Mr. Robert W. Cook, Seasoned Biotech Executive, Joins RenovaCare as Chief Financial Officer and Board Secretary

Jun 10, 2020 08:36AM RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services

May 28, 2020 08:30AM RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment

May 26, 2020 08:30AM RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer

Mar 30, 2020 08:32AM Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London

Mar 11, 2020 08:30AM RenovaCare Announces New Corporate Headquarters and Laboratory Facilities

Dec 5, 2019 08:30AM RenovaCare Stockholder Update and 2020 Outlook from the CEO

Nov 26, 2019 08:30AM Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare

Nov 18, 2019 08:30AM RenovaCare Appoints Alan L. Rubino as President and CEO

Sep 24, 2019 08:30AM Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare

Aug 20, 2019 08:30AM Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare

Aug 14, 2019 08:30AM RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues

Jul 11, 2019 08:30AM Former Johnson & Johnson Worldwide Director for Advanced Wound Care Joins RenovaCare

Jun 27, 2019 08:38AM RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing

Jun 6, 2019 08:30AM Vice President to Expand RenovaCare SkinGun™ Technology for New Medical Conditions Beyond Burns

Mar 21, 2018 08:30AM RenovaCare Board of Directors Elects Majority Stockholder Harmel S. Rayat as Chairman

Feb 15, 2018 08:30AM RenovaCare Announces Successful FDA Meeting

Jan 9, 2018 08:30AM RenovaCare 2018 Outlook and Shareholder Update from the CEO

Oct 31, 2017 09:00AM RenovaCare SkinGun™ Stem Cell Sprayer on Exhibit at the Science Museum in London